Literature DB >> 27091028

Substance Use and Adherence Among People Living with HIV/AIDS Receiving cART in Latin America.

Raquel B De Boni1, Bryan E Shepherd2, Beatriz Grinsztejn3, Carina Cesar4, Claudia Cortés5, Denis Padgett6, Eduardo Gotuzzo7, Pablo F Belaunzarán-Zamudio8, Peter F Rebeiro2, Stephany N Duda2, Catherine C McGowan2.   

Abstract

This cross-sectional study describes substance use prevalence and its association with combination antiretroviral therapy (cART) adherence among 3343 individuals receiving care at HIV clinics in Argentina, Brazil, Chile, Honduras, Mexico, and Peru. A rapid screening tool evaluated self-reported 7-day recall of alcohol, marijuana, cocaine, heroin, and methamphetamine use, and missed cART doses. Overall, 29.3 % individuals reported having ≥1 alcoholic drinks, 5.0 % reported any illicit drug use and 17.0 % reported missed cART doses. In the logistic regression model, compared to no substance use, alcohol use [adjusted odds ratio (AOR) = 2.46, 95 % confidence interval (CI): 1.99-3.05], illicit drug use (AOR = 3.57, 95 % CI: 2.02-6.30), and using both alcohol and illicit drugs (AOR = 4.98, 95 % CI: 3.19-7.79) were associated with missed cART doses. The associations between substance use and likelihood of missing cART doses point to the need of targeting alcohol and illicit drug use to improve adherence among people living with HIV in Latin America.

Entities:  

Keywords:  Adherence; HIV/AIDS; Latin America; Substance use

Mesh:

Substances:

Year:  2016        PMID: 27091028      PMCID: PMC5069110          DOI: 10.1007/s10461-016-1398-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  40 in total

1.  Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users.

Authors:  L R Metsch; M Pereyra; T H Brewer
Journal:  J Subst Abuse       Date:  2001

Review 2.  Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme.

Authors:  Catherine C McGowan; Pedro Cahn; Eduardo Gotuzzo; Denis Padgett; Jean W Pape; Marcelo Wolff; Mauro Schechter; Daniel R Masys
Journal:  Int J Epidemiol       Date:  2007-09-10       Impact factor: 7.196

Review 3.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

4.  Perceived medical risks of drinking, alcohol consumption, and hepatitis C status among heavily drinking HIV primary care patients.

Authors:  Jennifer C Elliott; Efrat Aharonovich; Ann O'Leary; Barbara Johnston; Deborah S Hasin
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

Review 5.  Aging, antiretrovirals, and adherence: a meta analysis of adherence among older HIV-infected individuals.

Authors:  Luwam Ghidei; Mark J Simone; Marci J Salow; Kristin M Zimmerman; Allison M Paquin; Lara M Skarf; Tia R M Kostas; James L Rudolph
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923

6.  Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011.

Authors:  Christopher Rentsch; Janet P Tate; Kathleen M Akgün; Stephen Crystal; Karen H Wang; S Ryan Greysen; Emily A Wang; Kendall J Bryant; David A Fiellin; Amy C Justice; David Rimland
Journal:  AIDS Behav       Date:  2016-03

7.  Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse.

Authors:  Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

8.  The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

Authors:  Viviane D Lima; Richard Harrigan; David R Bangsberg; Robert S Hogg; Robert Gross; Benita Yip; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

9.  Illicit drug use and HIV treatment outcomes in a US cohort.

Authors:  Joseph Cofrancesco; Rebecca Scherzer; Phyllis C Tien; Cynthia L Gibert; Heather Southwell; Stephen Sidney; Adrian Dobs; Carl Grunfeld
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

Review 10.  Mental, neurological, and substance use disorders in people living with HIV/AIDS in low- and middle-income countries.

Authors:  Dixon Chibanda; Laura Benjamin; Helen A Weiss; Melanie Abas
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

View more
  13 in total

1.  Evaluating the care cascade after antiretroviral therapy initiation in Latin America.

Authors:  Marcelo J Wolff; Claudia P Cortes; Fernando A Mejìa; Denis Padgett; Pablo Belaunzarán-Zamudio; Beatriz Grinsztejn; Mark J Giganti; Catherine C McGowan; Peter F Rebeiro
Journal:  Int J STD AIDS       Date:  2017-06-15       Impact factor: 1.359

2.  Self-rated health and substance use among individuals in HIV care in Rio de Janeiro, Brazil: a cross-sectional study.

Authors:  Iona K Machado; Paula M Luz; Jordan E Lake; Rodolfo Castro; Luciane Velasque; Jesse L Clark; Valdilea G Veloso; Beatriz Grinsztejn; Raquel B De Boni
Journal:  Int J STD AIDS       Date:  2017-02-02       Impact factor: 1.359

Review 3.  Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Authors:  M Eugenia Socias; M-J Milloy
Journal:  Curr Infect Dis Rep       Date:  2018-07-31       Impact factor: 3.725

4.  Cumulative Burden of Mental Health Factors and Engagement in HIV Care in Argentina.

Authors:  Omar Sued; Diego Cecchini; John M Abbamonte; Violeta J Rodriguez; Lissa N Mandell; Nicholas V Cristofari; Maria Inés Figueroa; Isabel Cassetti; Pedro Cahn; Stephen M Weiss; Maria L Alcaide; Florencia Cahn; Liliana Calanni; Ana Crinejo; Daniel David; Sergio Lupo; Carolina Pérez; Rufina Pérez; Claudia Rodriguez; María José Rolón; Alicia Sisto; Liliana Trapé; Deborah L Jones
Journal:  Int J Behav Med       Date:  2021-06

Review 5.  HIV and Substance Use in Latin America: A Scoping Review.

Authors:  Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

6.  Examining Factors Associated with Gender Identity Among Individuals Disengaged from HIV Care in Argentina.

Authors:  Pablo D Radusky; Ines Aristegui; Lissa N Mandell; Emanuel Dell'Isola; Virginia Zalazar; Nadir Cardozo; María L Alcaide; Stephen M Weiss; Deborah L Jones; Omar Sued
Journal:  Int J Behav Med       Date:  2021-05-06

7.  Sociodemographic differences among HIV-positive and HIV-negative recently pregnant women in Mexico City: A case-control study.

Authors:  Daniel Aguilar-Zapata; Alicia Piñeirúa-Menéndez; Patricia Volkow-Fernández; Patricia Rodríguez-Zulueta; Ubaldo Ramos-Alamillo; Teresita Cabrera-López; Alexandra Martin-Onraet
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

8.  Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis.

Authors:  Jessica de Mattos Costa; Thiago Silva Torres; Lara Esteves Coelho; Paula Mendes Luz
Journal:  J Int AIDS Soc       Date:  2018-01       Impact factor: 5.396

Review 9.  An update on drug-drug interactions between antiretroviral therapies and drugs of abuse in HIV systems.

Authors:  Nuti Desai; Leah Burns; Yuqing Gong; Kaining Zhi; Asit Kumar; Nathan Summers; Santosh Kumar; Theodore J Cory
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-08-31       Impact factor: 4.481

10.  Is substance use associated with HIV cascade outcomes in Latin America?

Authors:  Raquel B De Boni; Meridith B Peratikos; Bryan E Shepherd; Beatriz Grinsztejn; Claudia Cortés; Denis Padgett; Eduardo Gotuzzo; Pablo F Belaunzarán-Zamudio; Peter F Rebeiro; Stephany N Duda; Catherine C McGowan
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.